Skip to main content

Table 1 Demographics, perioperative treatments, and outcomes in patients with or without acute kidney injury

From: Postoperative intubation time is associated with acute kidney injury in cardiac surgical patients

 

No AKI N =419

AKI N =165

Significance

Age (years)

67 (65 to 68)

72 (71 to 73)

P <0.001

Male/female (%)

272/147 (64.9/35.1)

108/57 (65.5/34.5)

P =0.98

Height (cm)

172 (170 to 173)

170 (168 to 172)

P =0.02

Weight (kg)

81 (80 to 84)

80 (78 to 83)

P =0.62

Additive Euroscore

4 (4 to 5)

6 (5 to 7)

P <0.001

Preoperative creatinine (μmol/l)

79 (77 to 82)

87 (82 to 94)

P <0.001

Preoperative eGFR § (ml/min/1.73 m2)

83.9 (80.5 to 86.2)

72.6 (67.6 to 78.4)

P <0.001

Preoperative diuretics

   

Y/N

227/192

103/62

P =0.065

(%)

54.2/ 45.8

62.4/37.6

ScO2 air (%)

63 (63 to 64)

61 (60 to 62)

P <0.001

ScO2 ox (%)

68 (67 to 69)

67 (65 to 68)

P =0.005

ScO2 minox (%)

62 (61 to 62)

59 (57 to 61)

P <0.001

Preoperative LVEF

   

- good

315 (75.1)

122 (73.9)

P =0.63

- moderate

88 (21)

38 (23)

- poor

16 (3.8)

4 (2.4)

CABG

   

- no

176 (42)

43 (26.1)

P <0.001

- yes

243 (58)

122 (73.9)

Duration of CPB (min)

110 (104 to 116)

128 (118 to 140)

P <0.001

Duration of surgery

245 (236 to 253)

272 (265 to 288)

P <0.001

Minimal hematocrit (%)

25 (25 to 26)

25 (24 to 25)

P =0.002

Minimal temperature during CBP (°C)

32 (32 to 32)

32 (32 to 32)

P =0.48

Blood products (units)

2 (1 to 2)

3 (2 to 4)

P <0.001

Cristalloids (ml)

4560 (4510 to 4640)

4580 (4450 to 4710)

P =0.84

Colloids (ml)

2000 (2000 to 2500)

2500 (2000 to 2500)

P =0.08

Drainage loss (ml)

800 (800 to 850)

950 (900 to 1000)

P <0.001

Postoperative urine flow (ml/24 h)

2930 (2869 to 3050)

2450 (2198 to 2650)

P <0.001

Postoperative diuretics

   

Y/N

381/38

145/20

P =0.444

(%)

90.9%/9.1%

87.8%/12.2%

Maximal postoperative lactate (mmol/l)

1.9 (1.7 to 1.9)

2.4 (2.2 to 2.7)

P <0.001

MAP baseline (%)

83 (82 to 85)

85 (82 to 89)

P =0.32

MAP mean IOP (mmHg)

71.7 (71.0 to 72.3)

70.7 (69.5 to 71.7)

P =0.11

CVP mean IOP (mmHg)

10.0 (9.3 to 10.3)

10.7 (10.0 to 11.5)

P =0.006

ScvO2 mean IOP (%)

81.5 (80.6 to 82.0)

80.9 (79.2 to 82.7)

P =0.34

SvO2 mean IOP * (%)

79.5 (78.5 to 80.7)

79.3 (77.6 to 80.2)

P =0.74

PAP mean IOP * (mmHg)

28.3 (23.5 to 26.2)

26.9 (24.4 to 29.6)

P =0.01

CI mean IOP * (l/min/m2)

2.9 (2.8 to 3.1)

1.8 (2.6 to 3.0)

P =0.07

MAP mean POP (mmHg)

75.2 (74.4 to 76.0)

72.6 (71.6 to 74.2)

P <0.001

CVP mean POP (mmHg)

14.7 (14.3 to 14.9)

15.2 (14.8 to 16.2)

P <0.001

ScvO2 mean POP (%)

70.6 (69.5 to 71.7)

69.3 (66.4 to 71.3)

P =0.09

SvO2 mean POP * (%)

68.4 (67.1 to 69.5)

68.5 (66.5 to 70.4)

P =0.86

PAP mean POP * (mmHg)

28.3 (27.6 to 29.2)

30.4 (29.0 to 32.2)

P =0.03

RPP mean POP (mmHg)

60.5 (59.9 to 61.4)

57.4 (56.0 to 59.0)

P <0.001

CI mean POP * (l/min/m2)

3.2 (3.0 to 3.3)

3.0 (2.8 to 3.1)

P =0.006

Dobutamine - IOP (no. of pts. (%))

  

P =0.03

0

195 (46.5)

60 (36.4)

<15 mg/h

93 (22.2)

37 (22.4)

15 - 30 mg/h

115 (27.4)

54 (32.7)

>30 mg/h

16 (3.8)

14 (8.5)

Dobutamine - POP (no. of pts. (%))

  

P <0.001

0

159 (37.9)

40 (24.2)

<15 mg/h

137 (32.7)

47 (28.5)

15 - 30 mg/h

107 (25.5)

57 (34.5)

>30 mg/h

16 (3.8)

21 (12.7)

PDE - III - IOP (no. of pts. (%))

  

P =0.001

0

258 (61.6)

77 (46.7)

Low dose

28 (6.7)

7 (4.2)

Moderate dose

124 (29.6)

74 (44.8)

High dose

10 (2.4)

7 (4.2)

PDE III-I - POP (no. of pts. (%))

  

P <0.001

0

216 (51.6)

55 (33.3)

Low dose

41 (9.8)

19 (11.5)

Moderate dose

145 (34.6)

79 (47.9)

High dose

16 (3.8)

12 (7.3)

Noradrenaline - IOP (no. of pts. (%))

  

P =0.054

0

51 (12.2)

11 (6.7)

<0.3 mg/h

192 (45.8)

69 (41.8)

0.3 - 0.6 mg/h

130 (31)

57 (34.5)

<0.6 mg/h

46 (10.9)

28 (16.9)

Noradrenaline - POP (no. of pts. (%))

  

P <0.001

0

72 (17.2)

18 (10.9)

<0.3 mg/h

205 (48.9)

57 (34.5)

0.3 - 0.6 mg/h

94 (22.4)

47 (28.5)

<0.6 mg/h

48 (11.5)

43 (26.1)

Vasopressine - IOP (no. of pts. (%))

  

P =0.016

0

393 (93.8)

142 (86.1)

<3 U/h

17 (4.1)

16 (9.7)

3 - 6 Uh

8 (1.9)

7 (4.2)

>6 U/h

1 (0.2)

0 (0)

Vasopressine - POP (no. of pts. (%))

  

P <0.001

0

384 (91.6)

137 (83)

<3 U/h

31 (7.4)

17 (10.3)

3 - 6 Uh

3 (0.7)

7 (4.2)

> 6 U/h

1 (0.2)

4 (2.4)

Time to first extubation (h)

7 (6 to 7)

8 (7 to 9)

P <0.001

Reintubation

  

P <0.001

No

409 (97.6)

133 (80.6)

Yes

9 (2.1)

32 (19.4)

Total ventilation time (h)

7 (6 to 7)

9 (7.4 to 11)

P <0.001

Duration of ICU treatment (h)

23 (22 to 23)

66 (38 to 81)

P <0.001

Duration of HDU treatment (h)

70 (65 to 77)

124 (108 to 144)

P <0.001

Mortality 30 d (no. of pts. (%))

1 (0.2)

10 (6.1)

P <0.001

  1. Continuous data are given as median and 95% confidence interval of the median; categorical data as absolute number with percentages in parenthesis. §Estimated glomerular filtration rate determined by the modifications of diet in renal disease equation; *data derived from patients monitored with pulmonary artery catheter. AKI: acute kidney injury; eGFR: estimated glomerular filtration rate; ScO2: cerebral oxygen saturation determined by near-infrared spectroscopy (ScO2air: bihemispheric mean values during room air; ScO2ox: bihemispheric mean values during oxygen supplementation; ScO2minox: lowest value of either side during oxygen supplementation); LVEF: left ventricular ejection fraction; CABG: coronary artery bypass grafting; CPB: cardiopulmonary bypass; IOP: intraoperatively; POP: postoperatively; MAP: mean arterial pressure; CVP: central venous pressure; PAP: mean pulmonary arterial pressure; ScvO2: central venous oxygen saturation; SvO2: mixed venous oxygen saturation; CI: cardiac index; RPP: renal perfusion pressure (MAP - CVP); PDE-III: phosphodiesterase III inhibitors (enoximone or milrinone), ICU: intensive care unit; HDU: high dependency unit. The amount of fluids, blood products (packed red cells and fresh frozen plasma) represents the volumes or units applied during surgery and within the first day on the ICU.